Multitargeted cancer prevention by quercetin

Canivenc-Lavier, 1996, Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver, Toxicology, 114, 19, 10.1016/S0300-483X(96)03412-9

Shih, 2000, Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer, Arch. Biochem. Biophys., 373, 287, 10.1006/abbi.1999.1550

Moon, 2006, Dietary flavonoids: effects on xenobiotic and carcinogen metabolism, Toxicol. In Vitro, 20, 187, 10.1016/j.tiv.2005.06.048

Price, 1997, Effect of storage and domestic processing on the contents and composition of flavonol glucosides in onion (Allium capa L.), J. Agric. Food Chem., 45, 938, 10.1021/jf9605916

Bors, 1990, Flavonoids as antioxidant; determination of radical-scavenging efficiencies, Methods Enzymol., 186, 343, 10.1016/0076-6879(90)86128-I

Yamamoto, 1999, Inhibitory effect of quercetin metabolites and their related derivatives on copper-induced lipid peroxidation in human low-density lipoprotein, Arch. Biochem. Biophys., 372, 347, 10.1006/abbi.1999.1516

Day, 2000, Conjugation position of quercetin glucuronides and effect on biological activity, Free Radic. Biol Med., 29, 1234, 10.1016/S0891-5849(00)00416-0

Kawanishi, 2005, Evaluation for safety of antioxidant chemopreventive agents, Antioxid. Redox Signal., 7, 1728, 10.1089/ars.2005.7.1728

Murota, 2000, Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2, Arch. Biochem. Biophys., 384, 391, 10.1006/abbi.2000.2123

Murota, 2005, Quercetin appears in the lymph of unsaturated rats at its phase II metabolites after administered into the stomach, FEBS Lett., 579, 5343, 10.1016/j.febslet.2005.08.060

Day, 2001, Human metabolism of dietary flavonoids; identification of plasma metabolites of quercetin, Free Radic. Res., 212, 941, 10.1080/10715760100301441

Williamson, 2005, In vitro biological properties of flavonoid conjugates found in vivo, Free Radic. Res., 39, 457, 10.1080/10715760500053610

Moon, 2000, Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women, Am. J. Physiol. Regul. Integr. Comp. Physiol., 279, R461, 10.1152/ajpregu.2000.279.2.R461

De Boer, 2005, Tissue distribution of quercetin in rats and pigs, J. Nutr., 135, 1718, 10.1093/jn/135.7.1718

Shimoi, 2001, Deconjugation of a flavonoid, luteolin monoglucuronide, during inflammation, Drug Metab. Dispos., 29, 1521

Kawai, 2008, Mjacrophase as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic melanism of dietary flavonoids, J. Biol. Chem., 283, 9424, 10.1074/jbc.M706571200

Tachibana, 2004, A receptor for green tea polyphenol EGCG, Nat. Struct. Mol. Biol., 11, 380, 10.1038/nsmb743

Li, 2007, Direct inhibition of insulin-like growth factor-I receptor kinase activity by (−)-epigallocatechin-3-gallate regulates cell transformation, Cancer Epidemiol. Biomarkers Prev., 16, 598, 10.1158/1055-9965.EPI-06-0892

Ermakova, 2005, The intermediate filament protein vimentin is a new target for epigallocatechin gallate, J. Biol. Chem., 280, 16882, 10.1074/jbc.M414185200

Ermakova, 2006, (−)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78, Cancer Res., 66, 9260, 10.1158/0008-5472.CAN-06-1586

Lee, 2008, Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine, Cancer Res., 68, 946, 10.1158/0008-5472.CAN-07-3140

Denison, 2002, Ligand binding and activation of the Ah receptor, Chem. Biol. Interact., 141, 3, 10.1016/S0009-2797(02)00063-7

Denison, 2003, Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals, Annu. Rev. Pharmacol. Toxicol., 43, 309, 10.1146/annurev.pharmtox.43.100901.135828

Guengerich, 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes, Chem. Res. Toxicol., 4, 391, 10.1021/tx00022a001

Ashida, 2000, Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin, FEBS Lett., 476, 213, 10.1016/S0014-5793(00)01730-0

Fukuda, 2007, Interaction between the aryl hydrocarbon receptor and its antagonists, flavonoids, Biochem. Biophys. Res. Commun., 359, 822, 10.1016/j.bbrc.2007.05.199

Fukuda, 2008, Suppressive effects of flavonoids on activation of the aryl hydrocarbon receptor induced by dioxins, 368

van der Woude, 2005, The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor, Mol. Nutr. Food Res., 49, 763, 10.1002/mnfr.200500036

Cappelletti, 2006, Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells, Int. J. Oncol., 28, 1185

Xing, 2001, Quercetin inhibits expression and function of the androgen receptor in LNCaP prostate cancer cells, Carcinogenesis, 22, 409, 10.1093/carcin/22.3.409

Yuan, 2004, Overexpression of c-Jun induced by quercetin and resverol inhibits the expression and function of the androgen receptor in human prostate cancer cells, Cancer Lett., 213, 155, 10.1016/j.canlet.2004.04.003

Yuan, 2005, Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells, Carcinogenesis, 26, 793, 10.1093/carcin/bgi021

Kim, 2005, Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells, J. Nutr. Biochem., 16, 155, 10.1016/j.jnutbio.2004.10.010

Chen, 2007, Induction of death receptor 5 and suppression of surviving contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells, Carcinogenesis, 28, 2114, 10.1093/carcin/bgm133

Psahoulia, 2007, Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts, Mol. Cancer Ther., 6, 2591, 10.1158/1535-7163.MCT-07-0001

Granado-Serrano, 2006, Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2), J. Nutr., 136, 2715, 10.1093/jn/136.11.2715

Duraj, 2005, Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants, Neoplasma, 52, 273

Ishikawa, 2000, Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways, Kidney Int., 58, 1078, 10.1046/j.1523-1755.2000.00265.x

Marone, 2001, Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases, Exp. Cell Res., 270, 1, 10.1006/excr.2001.5326

Ferraresi, 2005, Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin, Free Radic. Res., 39, 1249, 10.1080/10715760500306935

Robaszkiewicz, 2007, Antioxidative and prooxidative effects of quercetin on A549 cells, Cell Biol. Int., 31, 1245, 10.1016/j.cellbi.2007.04.009

Zebisch, 2007, Signaling through RAS–RAF–MEK–ERK: from basics to bedside, Curr. Med. Chem., 14, 601, 10.2174/092986707780059670

Nguyen, 2004, The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells, Carcinogenesis, 25, 647, 10.1093/carcin/bgh052

Cho, 2003, Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage, Mol. Cell. Biochem., 243, 153, 10.1023/A:1021624520740

Dias, 2005, Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats, J. Nutr., 135, 2299, 10.1093/jn/135.10.2299

Psahoulia, 2007, Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells, Carcinogenesis, 28, 1021, 10.1093/carcin/bgl232

Lee, 2005, Nrf2 as a novel molecular target for chemoprevention, Cancer Lett., 224, 171, 10.1016/j.canlet.2004.09.042

Yao, 2007, Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways, J. Hepatol., 47, 253, 10.1016/j.jhep.2007.02.008

Tanigawa, 2007, Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin, Free Radic. Biol. Med., 42, 1690, 10.1016/j.freeradbiomed.2007.02.017

Donnini, 2006, Divergent effects of quercetin conjugates on angiogenesis, Br. J. Nutr., 95, 1016, 10.1079/BJN20061753

Yang, 2006, Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis, Drug Metab. Dispos., 34, 296, 10.1124/dmd.105.005280

Sengupta, 2001, Modulation of DMBA induced genotoxicity in bone marrow by quercetin during skin carcinogenesis, J. Exp. Clin. Cancer Res., 20, 131

Shirai, 2006, Effect of a conjugated quercetin metabolite, quercetin 3-glucuronide, on lipid hydroperoxide-dependent formation of reactive oxygen species in differentiated PC-12 cells, Free Radic. Res., 40, 1047, 10.1080/10715760600794287

Dihal, 2006, Quercetin, but not its glycosylated conjugate rutin, inhibits azoxymethane-induced colorectal carcinogenesis in F344 rats, J. Nutr., 136, 2862, 10.1093/jn/136.11.2862

Volate, 2005, Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin), Carcinogenesis, 26, 1450, 10.1093/carcin/bgi089

Femia, 2003, Effect of diets fortified with tomatoes or onions with variable quercetin-glycoside content on azoxymethane-induced aberrant crypt foci in the colon of rats, Eur. J. Nutr., 42, 346, 10.1007/s00394-003-0431-5

Kwon, 2005, Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression, Biochem. Pharmacol., 69, 395, 10.1016/j.bcp.2004.10.015

van der Logt, 2003, Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens, Carcinogenesis, 24, 1651, 10.1093/carcin/bgg117

Shimoi, 2005, Glucuronidase deconjugation in inflammation, Methods Enzymol., 400, 263, 10.1016/S0076-6879(05)00015-7

Oi, 2008, Metabolic conversion of dietary quercetin from its conjugate to active aglycone following the induction of hepatocarcinogenesis in Fisher 344 rats, J. Agric. Food. Chem., 56, 577, 10.1021/jf072556c

Ross, 2002, Dietary flavonoids: bioavailability, metabolic effects, and safety, Annu. Rev. Nutr., 22, 19, 10.1146/annurev.nutr.22.111401.144957

Neuhouser, 2004, Dietary flavonoids and cancer risk: evidence from human population studies, Nutr. Cancer, 50, 1, 10.1207/s15327914nc5001_1

Arts, 2005, Polyphenols and disease risk in epidemiologic studies, Am. J. Clin. Nutr., 81, 317S, 10.1093/ajcn/81.1.317S

Hirvonen, 2001, Flavonol and flavone intake and the risk of cancer in male smokers (Finland), Cancer Causes Control, 12, 789, 10.1023/A:1012232008016

De Stefani, 1999, Dietary antioxidants and lung cancer risk: a case-control study in Uruguay, Nutr. Cancer, 34, 100, 10.1207/S15327914NC340114

Hertog, 1993, Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands, Nutr. Cancer, 20, 21, 10.1080/01635589309514267

Knekt, 2002, Flavonoid intake and risk of chronic diseases, Am. J. Clin. Nutr., 76, 560, 10.1093/ajcn/76.3.560

Nöthlings, 2007, Flavonols and pancreatic cancer risk: the multiethnic cohort study, Am. J. Epidemiol., 166, 924, 10.1093/aje/kwm172

Gates, 2007, A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer, Int. J. Cancer, 121, 2225, 10.1002/ijc.22790

Hou, 2005, Mechanism of action of (−)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells, Cancer Res., 65, 8049, 10.1158/0008-5472.CAN-05-0480

Deschner, 1991, Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia, Carcinogenesis, 12, 1193, 10.1093/carcin/12.7.1193

Gee, 2002, Suppression of intestinal crypt cell proliferation and aberrant crypt foci by dietary quercetin in rats, Nutr. Cancer, 43, 193, 10.1207/S15327914NC432_10

Matsukawa, 1997, Effects of quercetin and/or restraint stress on formation of aberrant crypt foci induced by azoxymethane in rat colons, Oncology, 54, 118, 10.1159/000227674

Pereira, 1996, Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats, Carcinogenesis, 17, 1305, 10.1093/carcin/17.6.1305

Deschner, 1993, The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet, Nutr. Cancer, 20, 199, 10.1080/01635589309514287

Mahmoud, 2000, Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis, Carcinogenesis, 21, 921, 10.1093/carcin/21.5.921

Makita, 1996, Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin, Cancer Res., 56, 904

Verma, 1998, Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin, Cancer Res., 48, 5754

Kato, 1983, Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition, Carcinogenesis, 4, 1301, 10.1093/carcin/4.10.1301

Khanduja, 1999, Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice, Food Chem. Toxicol., 37, 313, 10.1016/S0278-6915(99)00021-6